« Return to News | Awards & Advancement

Theorem names Rosenfeld as vice president

Friday, March 23, 2012 03:28 PM

Theorem Clinical Research, a full-service CRO, has appointed Evan Rosenfeld, M.D., J.D., F.C.L.M., as vice president of medical and scientific affairs, medical device and diagnostics.

Rosenfeld has more than 10 years experience within the medical device and diagnostic industries as both an attorney and medical director. He has previously served at Emergo Group as the medical director and senior consultant for regulatory and clinical affairs. At the same time, Rosenfeld founded MDJD Consulting and worked as an independent consultant. He has also worked at Microtransponder as the chief medical officer/senior vice president of regulatory affairs and at Bioness as chief medical officer/vice president of medical and regulatory affairs.

Rosenfeld is also fellow of the American College of Legal Medicine and holds membership with the Commonwealth of Pennsylvania Bar, the United States Patent and Trademark Office Bar, the District of Columbia Bar and the State of Illinois Bar.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.